Close

Drug Research

Aegis wins US patent for octreotide formulations

Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for...

Antares, Watson Pharmaceuticals launch Gelnique 3% in US

Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the treatment of overactive bladder. The product...

Meridian, Teva settle epinephrine auto-injector pending patent litigation

Meridian Medical Technologies, a Pfizer subsidiary, and Teva have entered into a settlement agreement to resolve generic epinephrine auto-injector pending patent litigation. ...

Affymax, Takeda launch OMONTYS injection in US

Affymax and Takeda Pharmaceutical Company have announced the availability of OMONTYS injection to treat anemia due to chronic kidney disease (CKD) in adult patients...

Watson introduces generic version of Fortamet

Watson Pharmaceuticals has introduced an authorized generic version of Fortamet as a part of an agreement with Shionogi. The company...

Elis Pharma to present erectile dysfunction drug Vitaros at...

Elis Pharmaceuticals will present erectile dysfunction drug Vitaros licensed from Apricus Biosciences at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), as...

EyeScience develops new eye vitamin for diabetes patients

EyeScience Labs, a resource in ocular nutrition and maker of EyeScience Macular Health Formula and EyeScience Dry Eye Formula, has developed a new eye...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read